[1] R. Ramli et al., “Morbidly adherent placenta: One-year case series in a tertiary hospital,” Medical Journal of Malaysia, vol. 74, no. 2, pp. 128–132, 2019.
[2] A. Naser, V. Praveen, S. Kurian, and S. Ajith, “Study of maternal and neonatal outcomes of placenta accreta spectrum in a tertiary care hospital,” vol. 14, no. 5, pp. 108–115, 2023.
[3] A. Slaoui et al., “Placenta accreta in the department of gynaecology and obstetrics in Rabat, Morocco: Case series and review of the literature,” Pan African Medical Journal, vol. 33, pp. 1–12, 2019.
[4] W. Pan et al., “Uterus-preserving surgical management of placenta accreta spectrum disorder : a large retrospective study,” pp. 1–9, 2023.
[5] D. K. Chan and A. B. Olawaiye, “Clinics in Mother and Child Health Management of the Morbidly Adherent Placenta,” vol. 16, no. 1000323, pp. 1–3, 2019.
[6] C. Dane, E. Kızıldag, S. Güleç, and B. Dane, “Five cases of placenta previa accreta : the maternal and fetal outcome from a tertiary center,” vol. 5, no. 1, pp. 24–27, 2023.
[7] A. M. Maged et al., “Diagnostic accuracy of ultrasound in the diagnosis of Placenta accreta spectrum : systematic review and meta ‑ analysis,” pp. 1–18, 2023.
[8] A. Kansouh and E. Serag Eldin, “Maternal outcomes after different surgical techniques in placenta accreta: a prospective study,” Journal of Medicine in Scientific Research, vol. 1, no. 4, p. 306, 2018.
[9] E. Jauniaux et al., “FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction,” International Journal of Gynecology and Obstetrics, vol. 140, no. 3, pp. 261–264, 2018.
[10] A. Shehata, N. Hussein, A. El-Halwagy, and A. El Gergawy, “Could Simple Procedures Minimize Hysterectomy in Management of Placenta Accreta?,” Indian Journal of Obstetrics and Gynecology Research, vol. 2, no. 4, p. 213, 2015.
[11] A. Richa, S. Amita, and V. Neelam, “Morbidly Adherent Placenta : A Critical Review,” vol. 62, no. February, pp. 57–61, 2012.
[12] M. Kasraeian et al., “A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women,” BMC Women’s Health, vol. 21, no. 1, pp. 1–6, 2021.
[13] N. Tahir, M. Adil, B. Afzal, S. Kiani, R. Kiani, S. Khan. Definitive Management of Morbidly Adhernt Placenta: Analysis of Maternal Outcomes. Pakistan Armed Forces Medical Journal, 68 (5): 1156-60, 2018.
[14] R. Wajid, S. Bashir, and A. Hanif, “Treatment Outcome of Adherent Placenta: An Experience at Tertiary Care Hospital,” Annals of King Edward Medical University, vol. 23, no. 1, pp. 23–28, 2017.
[15] S. Gupta, N. P. Jain, S. K. Singla, S. K. Juneja, R. Aggarwal, and L. Khanna, “Clinical Profile of Morbidly Adherent Placenta.,” National Journal of Integrated Research in Medicine, vol. 8, no. 3, pp. 36–40, 2017.
[16] H. Zhao et al., “Risk factors of emergency cesarean section in pregnant women with severe placenta accreta spectrum : a retrospective cohort study, Frontiers in Medicine” vol. 10, no. July, pp. 1–9, 2023.
[17] S. Takeda, J. Takeda, and Y. Murayama, “Placenta Previa Accreta Spectrum: Cesarean Hysterectomy,” The Surgery Journal, vol. 07, no. S 01, pp. S28–S37, 2021.
[18] D. V. Rani, D. S. Jain, D. S. Nanda, D. V. M. D. M. B. Chauhanand, and D. N. Sangwan, “Placenta accrete spectrum-management and fetomaternal outcome at a tertiary care centre,” International Journal of Clinical Obstetrics and Gynaecology, vol. 3, no. 5, pp. 84–89, 2019.
[19] J. L. Bailit et al., “Morbidly Adherent Placenta Treatments and Outcomes HHS Public Access Author manuscript,” Obstet Gynecol, vol. 125, no. 3, pp. 683–689, 2015.
[20] V. Malhotra, V. Bhuria, S. Nanda, M. Chauhan, and A. Rani, “Placenta accreta: Five-year experience at a tertiary-care center,” Journal of Gynecologic Surgery, vol. 30, no. 2, pp. 91–95, 2014.
[21] A. A. Hasan, J. A. Hasan, A. A. Khan.Management and Maternal Outcome in Morbidly Adhrent Placenta. Journal of Surgery Pakistan (International), 14 (4): 166-169,2009.
[22] A. J. Nieto-Calvache et al., “Placenta Accreta Spectrum Prenatal Diagnosis Performance: Are Ultrasound False-positive Results Acceptable in Limited-resources Settings?,” Revista Brasileira de Ginecologia e Obstetricia, vol. 44, no. 9. pp. 838–844, 2022.
[23] G. Kayem, C. Davy, F. Goffinet, C. Thomas, D. Cléent, and D. Cabrol, “Conservative versus extirpative management in cases of placenta accreta,” Obstetrics and Gynecology, vol. 104, no. 3, pp. 531–536, 2004.
[24] N. Yasmeen, S. Ahmad, Z. Khanum, F. Khanum, and S. Khan, “Fetomaternal Out Come in Placenta Accreta Spectrum (Pas)in a Tertiary Care Teaching Hospital,” JAIMC: Journal of Allama Iqbal Medical College, vol. 21, no. 1, pp. 34–39, 2023.
[25] S. Talib SalmanMBChB, C. Ali Hassan MohammedMBChB, C. Nadhim Ghazal NoamanMBChB, and H. Khaleel Ibrahim, “Prevalence of placenta accreta in Diyala governorate during 2010-2012 years,” Tikrit Medical Journal, vol. 19, no. 2, pp. 286–295, 2013.
[26] C. R. Warshak et al., “Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta,” Obstetrics and Gynecology, vol. 115, no. 1, pp. 65–69, 2010.